CHLORPROMAZINE

CHLORPROMAZINE was reported 6281 times

CHLORPROMAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOHALLUCINATION 5 0.1613
1 DELUSION OF GRANDEUR 71 0.1581
2 CONGENITAL CEREBROVASCULAR ANOMALY 9 0.1525
3 DECREASED EYE CONTACT 33 0.1086
4 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA 5 0.0980
5 FOETAL ALCOHOL SYNDROME 9 0.0900
6 NEUTROPENIA NEONATAL 19 0.0848
7 OPPOSITIONAL DEFIANT DISORDER 32 0.0810
8 ANTISOCIAL PERSONALITY DISORDER 8 0.0620
9 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 9 0.0608
10 INTERCOSTAL RETRACTION 4 0.0563
11 ELECTROCONVULSIVE THERAPY 6 0.0550
12 DISSEMINATED HERPES SIMPLEX 4 0.0541
13 MANIC SYMPTOM 9 0.0536
14 LYMPHOCYTE COUNT ABNORMAL 56 0.0497
15 DEXTROCARDIA 9 0.0479
16 PORTAL TRACT INFLAMMATION 6 0.0476
17 ACANTHOSIS NIGRICANS 8 0.0432
18 SPASMODIC DYSPHONIA 11 0.0363
19 CONVULSIVE THRESHOLD LOWERED 14 0.0356
20 ELECTRIC SHOCK 28 0.0327
21 EMOTIONAL POVERTY 56 0.0319
22 CHOREOATHETOSIS 21 0.0309
23 FLOPPY IRIS SYNDROME 11 0.0298
24 ATHETOSIS 5 0.0287
25 PNEUMOCONIOSIS 6 0.0286
26 WAXY FLEXIBILITY 5 0.0284
27 FOETAL DISORDER 23 0.0275
28 GRANDIOSITY 10 0.0273
29 EPILEPTIC ENCEPHALOPATHY 6 0.0269
30 ADAMS-STOKES SYNDROME 4 0.0260
31 ECHOLALIA 8 0.0252
32 NEUROBLASTOMA 9 0.0235
33 NEUROLEPTIC MALIGNANT SYNDROME 262 0.0221
34 PROCTECTOMY 6 0.0218
35 CEREBRAL AMYLOID ANGIOPATHY 7 0.0212
36 POSTURING 11 0.0212
37 RHINALGIA 58 0.0211
38 CATATONIA 107 0.0204
39 WRONG PATIENT 10 0.0199
40 POLYSEROSITIS 8 0.0188
41 ONYCHOPHAGIA 5 0.0181
42 PARASOMNIA 13 0.0181
43 ILEOSTOMY CLOSURE 6 0.0179
44 TRICHOGLOSSIA 7 0.0171
45 VICTIM OF CRIME 21 0.0170
46 GLIOSIS 7 0.0163
47 BLOOD FOLATE DECREASED 11 0.0151
48 CENTRAL HYPOTHYROIDISM 5 0.0151
49 OROMANDIBULAR DYSTONIA 11 0.0151
50 APRAXIA 22 0.0148
51 INTESTINAL PSEUDO-OBSTRUCTION 13 0.0148
52 WATER INTOXICATION 7 0.0138
53 HEAD TITUBATION 19 0.0138
54 VASOCONSTRICTION 12 0.0137
55 COGWHEEL RIGIDITY 14 0.0133
56 ELECTROCARDIOGRAM QT SHORTENED 4 0.0132
57 ANTIPSYCHOTIC DRUG LEVEL INCREASED 37 0.0131
58 OVARIAN FAILURE 7 0.0131
59 SCHIZOPHRENIA 159 0.0131
60 PARKINSONIAN GAIT 8 0.0128
61 OPISTHOTONUS 10 0.0126
62 EOSINOPHILIC MYOCARDITIS 9 0.0123
63 PRIAPISM 41 0.0119
64 VISCERAL CONGESTION 6 0.0117
65 MUTISM 16 0.0110
66 RESTING TREMOR 7 0.0108
67 AFFECTIVE DISORDER 85 0.0108
68 NEGATIVISM 8 0.0105
69 GRIMACING 8 0.0102
70 VERBAL ABUSE 5 0.0102
71 ANASTOMOTIC LEAK 7 0.0101
72 PLEUROTHOTONUS 9 0.0100
73 HYPERKINESIA 21 0.0099
74 ALTERED VISUAL DEPTH PERCEPTION 8 0.0098
75 HOMICIDAL IDEATION 39 0.0096
76 SCHIZOAFFECTIVE DISORDER 17 0.0095
77 GLOMERULOSCLEROSIS 6 0.0095
78 NEUTROPHIL COUNT INCREASED 96 0.0094
79 HYPERTONIA NEONATAL 5 0.0093
80 PARKINSONISM 91 0.0093
81 INTESTINAL ANASTOMOSIS 6 0.0093
82 PERFORATED ULCER 7 0.0093
83 SELF-DESTRUCTIVE BEHAVIOUR 8 0.0092
84 HYPOPARATHYROIDISM 7 0.0091
85 POLYDIPSIA 36 0.0091
86 CARBON DIOXIDE DECREASED 10 0.0087
87 POST-TRAUMATIC NECK SYNDROME 7 0.0087
88 BILIARY SEPSIS 4 0.0086
89 APGAR SCORE LOW 11 0.0085
90 HALLUCINATION, AUDITORY 135 0.0085
91 STEREOTYPY 8 0.0085
92 BORDERLINE PERSONALITY DISORDER 6 0.0085
93 SOMATIC SYMPTOM DISORDER 9 0.0083
94 DRUG-DISEASE INTERACTION 6 0.0082
95 POUCHITIS 7 0.0081
96 EOSINOPHIL COUNT DECREASED 19 0.0080
97 CEREBELLAR ATROPHY 7 0.0079
98 SOFT TISSUE INJURY 6 0.0079
99 THERAPEUTIC PRODUCT CROSS-REACTIVITY 7 0.0078
100 PSYCHOMOTOR RETARDATION 22 0.0078
101 COAGULATION TEST ABNORMAL 6 0.0078
102 PREMATURE MENOPAUSE 7 0.0076
103 ABULIA 7 0.0076
104 EPHELIDES 4 0.0074
105 POISONING DELIBERATE 70 0.0074
106 SALIVARY HYPERSECRETION 73 0.0073
107 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 8 0.0073
108 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 5 0.0072
109 LONG QT SYNDROME 17 0.0071
110 GAZE PALSY 12 0.0070
111 FOLATE DEFICIENCY 8 0.0069
112 TONIC CLONIC MOVEMENTS 9 0.0069
113 PSYCHOTIC DISORDER 202 0.0068
114 BLUNTED AFFECT 5 0.0068
115 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 6 0.0067
116 BRUXISM 36 0.0067
117 TORTICOLLIS 14 0.0066
118 HEAT STROKE 10 0.0066
119 SEDATION 171 0.0065
120 DISORGANISED SPEECH 12 0.0065
121 DISTURBANCE IN SOCIAL BEHAVIOUR 15 0.0064
122 EXTRAPYRAMIDAL DISORDER 158 0.0064
123 ARTERITIS 4 0.0063
124 HICCUPS 52 0.0063
125 ABDOMINAL COMPARTMENT SYNDROME 4 0.0063
126 ANTIPHOSPHOLIPID SYNDROME 10 0.0062
127 PSYCHOMOTOR SKILLS IMPAIRED 16 0.0061
128 ENCEPHALITIS AUTOIMMUNE 8 0.0061
129 HEPATIC CYTOLYSIS 77 0.0060
130 EPIDIDYMITIS 7 0.0060
131 PERSECUTORY DELUSION 15 0.0060
132 PSYCHOMOTOR HYPERACTIVITY 98 0.0059
133 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 4 0.0059
134 ENCEPHALITIS VIRAL 7 0.0057
135 PERSONALITY DISORDER 15 0.0057
136 ANTICHOLINERGIC SYNDROME 9 0.0056
137 LANGUAGE DISORDER 12 0.0055
138 AMNIOTIC CAVITY INFECTION 4 0.0055
139 ANGLE CLOSURE GLAUCOMA 14 0.0055
140 OCULAR TOXICITY 6 0.0054
141 HYPOMANIA 20 0.0054
142 HYPOSPADIAS 11 0.0053
143 NEPHROGENIC DIABETES INSIPIDUS 6 0.0052
144 MYOCLONUS 61 0.0051
145 MEGACOLON 8 0.0051
146 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 4 0.0051
147 LYMPHOCYTE COUNT DECREASED 90 0.0051
148 BLOOD PROLACTIN INCREASED 24 0.0051
149 MULTIPLE DRUG OVERDOSE 25 0.0050
150 TRISMUS 26 0.0050
151 BIPOLAR I DISORDER 11 0.0050
152 CHOLESTATIC LIVER INJURY 11 0.0049
153 LIBIDO INCREASED 10 0.0049
154 STERNAL FRACTURE 6 0.0049
155 HYPERAMMONAEMIA 24 0.0048
156 HALLUCINATIONS, MIXED 20 0.0048
157 HOSTILITY 12 0.0047
158 DYSTONIA 90 0.0046
159 PSYCHIATRIC DECOMPENSATION 9 0.0046
160 SOPOR 61 0.0046
161 STARING 11 0.0045
162 VIOLENCE-RELATED SYMPTOM 7 0.0045
163 HYPERLACTACIDAEMIA 12 0.0045
164 MUCOSAL DRYNESS 9 0.0045
165 GASTROINTESTINAL NECROSIS 13 0.0045
166 INHIBITORY DRUG INTERACTION 7 0.0044
167 RESPIRATORY DEPRESSION 54 0.0044
168 SARS-COV-2 TEST POSITIVE 58 0.0044
169 MYOCARDITIS 50 0.0044
170 MUSCLE RIGIDITY 52 0.0043
171 LABILE BLOOD PRESSURE 5 0.0042
172 ELECTROCARDIOGRAM CHANGE 4 0.0042
173 STREPTOCOCCAL INFECTION 23 0.0041
174 BRONCHOPNEUMONIA 14 0.0041
175 BLOOD ELECTROLYTES ABNORMAL 5 0.0040
176 ACUTE PSYCHOSIS 10 0.0040
177 DELIRIUM 140 0.0040
178 CLONUS 11 0.0040
179 FAECALOMA 22 0.0040
180 HYPERCAPNIA 12 0.0040
181 JAUNDICE CHOLESTATIC 14 0.0040
182 TORSADE DE POINTES 31 0.0039
183 TARDIVE DYSKINESIA 110 0.0039
184 ELECTROCARDIOGRAM QT PROLONGED 139 0.0039
185 WRONG PATIENT RECEIVED PRODUCT 11 0.0038
186 AFFECT LABILITY 36 0.0037
187 SINUS TACHYCARDIA 53 0.0037
188 HYPERREFLEXIA 13 0.0037
189 DISINHIBITION 6 0.0037
190 OCULOGYRIC CRISIS 8 0.0037
191 RESPIRATORY DISORDER NEONATAL 6 0.0037
192 HYPERPROLACTINAEMIA 24 0.0037
193 NEONATAL RESPIRATORY DISTRESS SYNDROME 13 0.0037
194 METABOLIC SYNDROME 6 0.0036
195 SELF-INJURIOUS IDEATION 15 0.0036
196 PROTHROMBIN TIME SHORTENED 5 0.0036
197 GASTROINTESTINAL HYPOMOTILITY 8 0.0035
198 BLOOD PH DECREASED 6 0.0035
199 ALTERED STATE OF CONSCIOUSNESS 76 0.0035
200 AGGRESSION 175 0.0035
201 DISTRACTIBILITY 4 0.0035
202 MANIA 57 0.0035
203 ACUTE PRERENAL FAILURE 4 0.0035
204 FLAT AFFECT 8 0.0035
205 DIABETES MELLITUS NON-INSULIN-DEPENDENT 5 0.0034
206 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
207 STUPOR 11 0.0034
208 LOW BIRTH WEIGHT BABY 27 0.0034
209 POLYCYTHAEMIA 7 0.0034
210 VENOUS THROMBOSIS LIMB 7 0.0034
211 AKINESIA 7 0.0034
212 BRADYPNOEA 9 0.0033
213 SUICIDE ATTEMPT 202 0.0033
214 NEUROGENIC BLADDER 7 0.0033
215 MONOCYTE COUNT INCREASED 12 0.0033
216 ANAEMIA MACROCYTIC 7 0.0033
217 MYOGLOBIN BLOOD INCREASED 5 0.0033
218 TONGUE ULCERATION 11 0.0033
219 NARCOLEPSY 6 0.0032
220 ELECTROENCEPHALOGRAM ABNORMAL 10 0.0032
221 PNEUMONIA ASPIRATION 79 0.0032
222 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
223 NEONATAL DISORDER 5 0.0032
224 INAPPROPRIATE AFFECT 5 0.0032
225 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
226 MEAN CELL VOLUME INCREASED 8 0.0031
227 CLEFT PALATE 6 0.0031
228 HYPOVENTILATION 10 0.0031
229 LEUKOCYTOSIS 55 0.0030
230 ALCOHOL POISONING 8 0.0030
231 DYSPHEMIA 13 0.0030
232 IMPULSIVE BEHAVIOUR 11 0.0029
233 INTENTIONAL SELF-INJURY 59 0.0029
234 ACCIDENTAL POISONING 4 0.0029
235 ILEUS PARALYTIC 13 0.0029
236 PSYCHOTIC SYMPTOM 6 0.0029
237 AGRANULOCYTOSIS 54 0.0029
238 DELUSION 45 0.0029
239 PHYSICAL ASSAULT 6 0.0029
240 OTORRHOEA 5 0.0029
241 SEROTONIN SYNDROME 55 0.0029
242 DRUG LEVEL INCREASED 47 0.0028
243 LEUKOPENIA 142 0.0028
244 DRUG LEVEL ABOVE THERAPEUTIC 13 0.0028
245 DYSKINESIA 115 0.0028
246 MUCOSAL INFLAMMATION 74 0.0028
247 POSTURE ABNORMAL 9 0.0028
248 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
249 CEREBRAL ATROPHY 11 0.0028
250 STATUS EPILEPTICUS 31 0.0027
251 BLOOD CREATINE PHOSPHOKINASE INCREASED 79 0.0027
252 AMMONIA INCREASED 14 0.0027
253 SEDATION COMPLICATION 7 0.0027
254 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
255 COORDINATION ABNORMAL 38 0.0027
256 POISONING 34 0.0027
257 COMA 128 0.0027
258 CHOLANGIOCARCINOMA 4 0.0027
259 BLOOD IRON INCREASED 5 0.0027
260 ORTHOSTATIC HYPOTENSION 46 0.0026
261 TROPONIN INCREASED 20 0.0026
262 DYSCHEZIA 8 0.0026
263 ALCOHOL ABUSE 7 0.0026
264 DROOLING 18 0.0026
265 FIBROSIS 8 0.0026
266 DRUG WITHDRAWAL SYNDROME NEONATAL 38 0.0026
267 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
268 PETIT MAL EPILEPSY 13 0.0025
269 DRUG SCREEN FALSE POSITIVE 7 0.0025
270 CIRCULATORY COLLAPSE 43 0.0025
271 DIABETIC COMA 7 0.0025
272 DRUG RESISTANCE 64 0.0025
273 RHABDOMYOLYSIS 102 0.0024
274 DRUG TOXICITY 33 0.0024
275 OVERWEIGHT 13 0.0024
276 ABDOMINAL HERNIA 11 0.0024
277 ACCIDENTAL EXPOSURE 10 0.0024
278 SNORING 9 0.0024
279 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 4 0.0024
280 ENCEPHALOPATHY 58 0.0024
281 INTENTIONAL OVERDOSE 151 0.0024
282 ILEOSTOMY 6 0.0023
283 AGITATION 170 0.0023
284 FOETAL DEATH 12 0.0023
285 EMBOLISM VENOUS 7 0.0023
286 SELF INJURIOUS BEHAVIOUR 7 0.0023
287 SUSPECTED COUNTERFEIT PRODUCT 9 0.0023
288 HYPOTHERMIA 23 0.0023
289 LOGORRHOEA 8 0.0023
290 HYPERTONIA 13 0.0023
291 DEPRESSED LEVEL OF CONSCIOUSNESS 89 0.0022
292 WHITE BLOOD CELL DISORDER 6 0.0022
293 METABOLIC DISORDER 13 0.0022
294 COLITIS ISCHAEMIC 15 0.0022
295 HYPERNATRAEMIA 11 0.0022
296 TOXICITY TO VARIOUS AGENTS 372 0.0022
297 AKATHISIA 30 0.0022
298 BRAIN INJURY 22 0.0022
299 BLOOD PHOSPHORUS DECREASED 8 0.0022
300 SUDDEN DEATH 23 0.0022
301 BODY TEMPERATURE ABNORMAL 4 0.0022
302 PARANOIA 37 0.0021
303 BILIRUBIN CONJUGATED INCREASED 5 0.0021
304 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
305 RENAL TUBULAR DISORDER 6 0.0021
306 MIOSIS 17 0.0021
307 BLOOD BICARBONATE DECREASED 4 0.0021
308 GRANULOCYTOPENIA 12 0.0021
309 PRE-ECLAMPSIA 10 0.0021
310 ASPIRATION 23 0.0021
311 COMPLETED SUICIDE 175 0.0021
312 HYPERTHERMIA 16 0.0021
313 POTENTIATING DRUG INTERACTION 7 0.0021
314 HYPOREFLEXIA 4 0.0021
315 NEUTROPHIL COUNT DECREASED 84 0.0021
316 BEHAVIOUR DISORDER 11 0.0020
317 CARDIOTOXICITY 18 0.0020
318 HEPATIC STEATOSIS 37 0.0020
319 DRUG ABUSE 165 0.0020
320 ENURESIS 8 0.0020
321 CHOLESTASIS 38 0.0020
322 FOETAL GROWTH RESTRICTION 12 0.0020
323 DUODENITIS 6 0.0020
324 GENERALISED TONIC-CLONIC SEIZURE 32 0.0019
325 IMPAIRED SELF-CARE 4 0.0019
326 CONGESTIVE CARDIOMYOPATHY 8 0.0019
327 HYPOCALCAEMIA 36 0.0019
328 FOETAL DISTRESS SYNDROME 4 0.0019
329 BRADYKINESIA 11 0.0019
330 PREMATURE BABY 56 0.0019
331 BLOOD SODIUM INCREASED 5 0.0019
332 DRUG INTERACTION 293 0.0018
333 LARGE INTESTINAL ULCER 5 0.0018
334 REFUSAL OF TREATMENT BY PATIENT 12 0.0018
335 BRADYPHRENIA 12 0.0018
336 WRONG PATIENT RECEIVED MEDICATION 5 0.0018
337 MATERNAL DRUGS AFFECTING FOETUS 14 0.0018
338 CELLULITIS 92 0.0018
339 NEUTROPENIA 248 0.0018
340 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
341 NEUTROPENIC SEPSIS 13 0.0018
342 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
343 THERAPEUTIC AGENT TOXICITY 6 0.0018
344 ANXIETY DISORDER 6 0.0018
345 TACHYCARDIA 158 0.0018
346 CARDIO-RESPIRATORY ARREST 74 0.0018
347 HEPATOMEGALY 17 0.0017
348 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
349 COMA SCALE ABNORMAL 5 0.0017
350 MOOD ALTERED 46 0.0017
351 ATAXIA 20 0.0017
352 CONGENITAL ANOMALY 13 0.0017
353 DYSARTHRIA 63 0.0017
354 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 43 0.0017
355 THERAPY NON-RESPONDER 75 0.0017
356 METABOLIC ENCEPHALOPATHY 5 0.0017
357 TREATMENT NONCOMPLIANCE 91 0.0017
358 PANIC REACTION 12 0.0017
359 HEPATITIS CHOLESTATIC 10 0.0017
360 NORMAL NEWBORN 9 0.0017
361 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17 0.0017
362 SEIZURE 191 0.0017
363 MUSCLE TWITCHING 38 0.0016
364 URINARY RETENTION 55 0.0016
365 FEBRILE BONE MARROW APLASIA 7 0.0016
366 ALCOHOL USE 6 0.0016
367 PSYCHIATRIC SYMPTOM 12 0.0016
368 SUICIDAL IDEATION 148 0.0016
369 HYPERACUSIS 6 0.0016
370 OLIGURIA 10 0.0016
371 NEPHROPATHY 15 0.0016
372 HEPATIC NECROSIS 6 0.0016
373 EXPOSURE VIA INGESTION 4 0.0016
374 KLEBSIELLA INFECTION 8 0.0016
375 HYPONATRAEMIA 89 0.0016
376 RESPIRATORY RATE INCREASED 14 0.0016
377 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
378 HEPATITIS 40 0.0016
379 HAEMOLYTIC ANAEMIA 14 0.0016
380 FEMORAL NECK FRACTURE 8 0.0016
381 GALACTORRHOEA 10 0.0016
382 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
383 HEPATOCELLULAR INJURY 22 0.0016
384 INCOHERENT 10 0.0015
385 CARDIOGENIC SHOCK 22 0.0015
386 POOR QUALITY SLEEP 33 0.0015
387 NASAL DISCOMFORT 12 0.0015
388 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 5 0.0015
389 BRAIN OEDEMA 19 0.0015
390 OLIGOHYDRAMNIOS 5 0.0015
391 DRUG-INDUCED LIVER INJURY 47 0.0015
392 MENTAL IMPAIRMENT 36 0.0015
393 NEUROTOXICITY 26 0.0015
394 TENSION 9 0.0015
395 CARDIAC TAMPONADE 7 0.0015
396 BIPOLAR DISORDER 16 0.0015
397 ABNORMAL BEHAVIOUR 58 0.0015
398 HEPATIC FIBROSIS 5 0.0015
399 FOETAL EXPOSURE DURING PREGNANCY 118 0.0015
400 HYPERBILIRUBINAEMIA 15 0.0014
401 INFUSION SITE EXTRAVASATION 9 0.0014
402 BLOOD UREA INCREASED 24 0.0014
403 EOSINOPHILIA 25 0.0014
404 BUNDLE BRANCH BLOCK LEFT 6 0.0014
405 OVERDOSE 304 0.0014
406 METABOLIC ACIDOSIS 45 0.0014
407 MENTAL STATUS CHANGES 39 0.0014
408 MYDRIASIS 18 0.0014
409 TEARFULNESS 6 0.0014
410 DYSPHORIA 7 0.0014
411 TOXIC ENCEPHALOPATHY 7 0.0014
412 PANCREATITIS ACUTE 31 0.0014
413 OBSESSIVE-COMPULSIVE DISORDER 11 0.0014
414 CARDIAC ARREST 113 0.0014
415 THROMBOCYTOSIS 5 0.0014
416 IRRITABILITY 82 0.0014
417 PROTEIN TOTAL DECREASED 5 0.0013
418 CONVULSION 75 0.0013
419 HAEMATOCRIT DECREASED 26 0.0013
420 HYPOTONIA 13 0.0013
421 ENCEPHALITIS 9 0.0013
422 GRAND MAL CONVULSION 12 0.0013
423 NEPHROGENIC ANAEMIA 6 0.0013
424 NEOPLASM PROGRESSION 45 0.0013
425 PULMONARY CONGESTION 17 0.0013
426 SPLENOMEGALY 15 0.0013
427 SEXUAL DYSFUNCTION 15 0.0013
428 HALLUCINATION, VISUAL 27 0.0013
429 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
430 BODY TEMPERATURE INCREASED 26 0.0013
431 AUTISM SPECTRUM DISORDER 7 0.0013
432 INTESTINAL ISCHAEMIA 7 0.0013
433 DISORIENTATION 50 0.0013
434 VENTRICULAR FIBRILLATION 14 0.0013
435 GESTATIONAL DIABETES 6 0.0013
436 BLOOD BILIRUBIN INCREASED 34 0.0013
437 INTRACRANIAL PRESSURE INCREASED 7 0.0013
438 PREMATURE DELIVERY 20 0.0013
439 TREATMENT FAILURE 104 0.0013
440 FAECAL INCONTINENCE 6 0.0012
441 URINARY INCONTINENCE 37 0.0012
442 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
443 COLECTOMY 7 0.0012
444 WRONG DRUG ADMINISTERED 11 0.0012
445 MENTAL DISORDER 53 0.0012
446 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
447 GENERALISED OEDEMA 15 0.0012
448 EMBOLISM 10 0.0012
449 STRESS CARDIOMYOPATHY 7 0.0012
450 SPEECH DISORDER 63 0.0012
451 RESTLESSNESS 44 0.0012
452 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
453 HAEMODYNAMIC INSTABILITY 9 0.0012
454 HYPERPYREXIA 5 0.0012
455 TACHYPNOEA 16 0.0012
456 SHOCK 27 0.0012
457 APATHY 17 0.0012
458 CRYING 42 0.0012
459 THERAPY PARTIAL RESPONDER 18 0.0012
460 INTENTIONAL PRODUCT MISUSE 101 0.0012
461 ANGER 39 0.0012
462 MOVEMENT DISORDER 37 0.0012
463 PARTIAL SEIZURES 6 0.0011
464 LIVER INJURY 28 0.0011
465 PALLOR 31 0.0011
466 ATELECTASIS 11 0.0011
467 DEPRESSED MOOD 60 0.0011
468 DEPRESSIVE SYMPTOM 4 0.0011
469 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 7 0.0011
470 NYSTAGMUS 6 0.0011
471 THINKING ABNORMAL 21 0.0011
472 RESPIRATORY DISTRESS 31 0.0011
473 CONJUNCTIVAL HYPERAEMIA 4 0.0011
474 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
475 FRUSTRATION 4 0.0011
476 JAUNDICE 30 0.0011
477 PANCYTOPENIA 62 0.0011
478 HYPOXIA 39 0.0011
479 HYPOKINESIA 16 0.0011
480 RESPIRATORY ARREST 30 0.0011
481 ISCHAEMIA 5 0.0011
482 EOSINOPHIL COUNT INCREASED 9 0.0011
483 HEPATOTOXICITY 24 0.0011
484 HEPATIC FUNCTION ABNORMAL 40 0.0011
485 ANGIOPATHY 6 0.0011
486 PREMATURE LABOUR 6 0.0011
487 PLATELET COUNT DECREASED 113 0.0011
488 THROMBOCYTOPENIA 118 0.0011
489 NEUTROPHILIA 6 0.0011
490 FACE INJURY 4 0.0011
491 SOMNOLENCE 212 0.0011
492 NEUROLOGICAL SYMPTOM 6 0.0010
493 PSEUDOMONAS INFECTION 9 0.0010
494 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
495 ACIDOSIS 8 0.0010
496 ILEUS 13 0.0010
497 COMMUNICATION DISORDER 4 0.0010
498 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
499 HYPERVENTILATION 6 0.0010
500 INTESTINAL OBSTRUCTION 39 0.0010
501 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
502 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
503 PRODUCT USE COMPLAINT 16 0.0010
504 PERITONITIS 21 0.0010
505 DIABETIC NEUROPATHY 5 0.0010
506 ANOREXIA 13 0.0010
507 FACE OEDEMA 17 0.0010
508 OBESITY 16 0.0010
509 PROTHROMBIN TIME PROLONGED 6 0.0010
510 ANAL INCONTINENCE 9 0.0010
511 INTRACRANIAL ANEURYSM 4 0.0010
512 CONFUSIONAL STATE 160 0.0010
513 LYMPHOPENIA 14 0.0010
514 END STAGE RENAL DISEASE 18 0.0010
515 SUBSTANCE ABUSE 8 0.0010
516 BLOOD CALCIUM DECREASED 11 0.0010
517 PHOTOSENSITIVITY REACTION 16 0.0010
518 ANHEDONIA 25 0.0010
519 PREGNANCY 19 0.0009
520 ALANINE AMINOTRANSFERASE INCREASED 58 0.0009
521 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
522 DEMENTIA 26 0.0009
523 MULTI-ORGAN FAILURE 16 0.0009
524 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
525 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
526 LETHARGY 53 0.0009
527 COGNITIVE DISORDER 43 0.0009
528 TIC 5 0.0009
529 OESOPHAGITIS 10 0.0009
530 NEUROPATHY PERIPHERAL 87 0.0009
531 HEPATITIS C 11 0.0009
532 DIABETES MELLITUS 69 0.0009
533 CONCUSSION 7 0.0009
534 BLOOD CREATINE INCREASED 4 0.0009
535 CARDIAC FAILURE ACUTE 6 0.0009
536 RASH MACULO-PAPULAR 20 0.0009
537 HYPOTENSION 179 0.0009
538 DRUG SCREEN POSITIVE 7 0.0009
539 BLOOD ALBUMIN DECREASED 7 0.0009
540 LUPUS-LIKE SYNDROME 8 0.0009
541 TREMOR 146 0.0009
542 MYOCARDIAL ISCHAEMIA 10 0.0009
543 ACUTE HEPATIC FAILURE 12 0.0009
544 EYE MOVEMENT DISORDER 6 0.0009
545 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
546 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
547 HYPERTRANSAMINASAEMIA 6 0.0009
548 HYPOMAGNESAEMIA 12 0.0009
549 PERSONALITY CHANGE 8 0.0009
550 RALES 5 0.0009
551 GAMMA-GLUTAMYLTRANSFERASE INCREASED 19 0.0009
552 HYPERAESTHESIA 7 0.0009
553 C-REACTIVE PROTEIN INCREASED 31 0.0009
554 LACERATION 8 0.0008
555 LIVE BIRTH 7 0.0008
556 HAEMODIALYSIS 7 0.0008
557 DYSPEPSIA 82 0.0008
558 ABNORMAL DREAMS 23 0.0008
559 DIABETIC KETOACIDOSIS 20 0.0008
560 DISEASE PROGRESSION 98 0.0008
561 THROMBOTIC MICROANGIOPATHY 8 0.0008
562 CHOKING 16 0.0008
563 PNEUMOTHORAX 13 0.0008
564 LOSS OF CONSCIOUSNESS 105 0.0008
565 FEAR 22 0.0008
566 RENAL FAILURE 108 0.0008
567 HYPOPHOSPHATAEMIA 6 0.0008
568 TRANSAMINASES INCREASED 18 0.0008
569 MOUTH ULCERATION 17 0.0008
570 CHOLANGITIS 5 0.0008
571 ABDOMINAL TENDERNESS 4 0.0008
572 HYPOGLYCAEMIA 39 0.0008
573 LACTIC ACIDOSIS 26 0.0008
574 TASTE DISORDER 16 0.0008
575 SCREAMING 5 0.0008
576 PRODUCT PRESCRIBING ISSUE 17 0.0008
577 RENAL FAILURE CHRONIC 6 0.0008
578 SLEEP DISORDER 55 0.0008
579 CACHEXIA 4 0.0008
580 PRESCRIBED OVERDOSE 15 0.0008
581 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
582 HALLUCINATION 58 0.0008
583 HERPES SIMPLEX 5 0.0008
584 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
585 STEVENS-JOHNSON SYNDROME 17 0.0008
586 WITHDRAWAL SYNDROME 32 0.0008
587 DISTURBANCE IN ATTENTION 41 0.0008
588 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
589 HYPOKALAEMIA 35 0.0008
590 INCONTINENCE 8 0.0008
591 ASCITES 22 0.0007
592 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
593 POST-TRAUMATIC STRESS DISORDER 5 0.0007
594 TYPE 2 DIABETES MELLITUS 25 0.0007
595 HYPERGLYCAEMIA 27 0.0007
596 ACCIDENTAL OVERDOSE 27 0.0007
597 RED BLOOD CELL COUNT DECREASED 21 0.0007
598 POLYURIA 6 0.0007
599 CARDIOMEGALY 9 0.0007
600 JAW DISORDER 4 0.0007
601 CHRONIC KIDNEY DISEASE 55 0.0007
602 ARRHYTHMIA 34 0.0007
603 PANIC ATTACK 26 0.0007
604 APPLICATION SITE REACTION 5 0.0007
605 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0007
606 HAEMATEMESIS 18 0.0007
607 THERMAL BURN 5 0.0007
608 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
609 ANURIA 6 0.0007
610 BACTERIAL INFECTION 13 0.0007
611 BLOOD MAGNESIUM DECREASED 6 0.0007
612 NIGHTMARE 24 0.0007
613 CARDIAC MURMUR 6 0.0007
614 HAEMOGLOBIN DECREASED 71 0.0007
615 PLATELET COUNT INCREASED 9 0.0007
616 BLOOD SODIUM DECREASED 13 0.0007
617 URINE OUTPUT DECREASED 6 0.0007
618 SLUGGISHNESS 7 0.0007
619 RESPIRATORY FAILURE 50 0.0007
620 DRUG WITHDRAWAL SYNDROME 60 0.0007
621 ORAL CANDIDIASIS 9 0.0007
622 INITIAL INSOMNIA 7 0.0007
623 TUMOUR LYSIS SYNDROME 6 0.0007
624 PULMONARY OEDEMA 30 0.0007
625 INSOMNIA 177 0.0007
626 HEAD INJURY 21 0.0007
627 BLOOD PRESSURE DECREASED 44 0.0007
628 COAGULOPATHY 11 0.0007
629 ACUTE KIDNEY INJURY 100 0.0007
630 HYPERHIDROSIS 84 0.0007
631 SMALL INTESTINAL OBSTRUCTION 8 0.0006
632 DECREASED ACTIVITY 7 0.0006
633 AMNESIA 42 0.0006
634 SEPTIC SHOCK 28 0.0006
635 MIDDLE INSOMNIA 12 0.0006
636 APNOEA 5 0.0006
637 ARTERIOSCLEROSIS 6 0.0006
638 INFUSION SITE SWELLING 4 0.0006
639 BLEPHAROSPASM 4 0.0006
640 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
641 MATERNAL EXPOSURE DURING PREGNANCY 56 0.0006
642 HYPOPHAGIA 16 0.0006
643 METASTASES TO LIVER 11 0.0006
644 MALNUTRITION 7 0.0006
645 ANXIETY 178 0.0006
646 ORAL PAIN 14 0.0006
647 SINUS BRADYCARDIA 6 0.0006
648 BLOOD POTASSIUM INCREASED 10 0.0006
649 HEPATITIS ACUTE 4 0.0006
650 CONDITION AGGRAVATED 186 0.0006
651 EXPOSURE DURING PREGNANCY 38 0.0006
652 GASTRITIS 16 0.0006
653 STAPHYLOCOCCAL INFECTION 20 0.0006
654 ELECTROLYTE IMBALANCE 7 0.0006
655 DEEP VEIN THROMBOSIS 39 0.0006
656 BLOOD CREATININE INCREASED 39 0.0006
657 QUALITY OF LIFE DECREASED 8 0.0006
658 TOXIC SKIN ERUPTION 6 0.0006
659 DRUG USE DISORDER 5 0.0006
660 ECONOMIC PROBLEM 9 0.0006
661 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
662 SUBARACHNOID HAEMORRHAGE 6 0.0006
663 IMPAIRED GASTRIC EMPTYING 8 0.0006
664 EUPHORIC MOOD 6 0.0006
665 RIB FRACTURE 12 0.0006
666 UNRESPONSIVE TO STIMULI 15 0.0006
667 PALPITATIONS 68 0.0006
668 MYOPATHY 5 0.0006
669 VENTRICULAR EXTRASYSTOLES 6 0.0006
670 PYELONEPHRITIS 5 0.0006
671 NO THERAPEUTIC RESPONSE 7 0.0006
672 RENAL IMPAIRMENT 48 0.0006
673 SPINAL OSTEOARTHRITIS 5 0.0006
674 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
675 RENAL FAILURE ACUTE 24 0.0006
676 FEBRILE NEUTROPENIA 37 0.0006
677 MYOSITIS 5 0.0006
678 EPILEPSY 17 0.0006
679 NERVOUSNESS 29 0.0006
680 DEVELOPMENTAL DELAY 5 0.0006
681 HYPERTHYROIDISM 8 0.0006
682 BRADYCARDIA 29 0.0005
683 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
684 IRON DEFICIENCY ANAEMIA 5 0.0005
685 BLOOD PRESSURE FLUCTUATION 13 0.0005
686 COVID-19 95 0.0005
687 CEREBRAL DISORDER 4 0.0005
688 DYSPHAGIA 51 0.0005
689 PULMONARY EMBOLISM 51 0.0005
690 PRODUCT USE IN UNAPPROVED INDICATION 133 0.0005
691 BLOOD POTASSIUM DECREASED 16 0.0005
692 DEPRESSION 120 0.0005
693 ACUTE RESPIRATORY FAILURE 10 0.0005
694 DEHYDRATION 69 0.0005
695 HYPOALBUMINAEMIA 4 0.0005
696 RENAL TUBULAR NECROSIS 5 0.0005
697 HEAD DISCOMFORT 9 0.0005
698 BLOOD IRON DECREASED 6 0.0005
699 RENAL INJURY 15 0.0005
700 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
701 HYPERLIPIDAEMIA 6 0.0005
702 VOMITING 236 0.0005
703 BLOOD DISORDER 4 0.0005
704 NOCTURIA 6 0.0005
705 DECUBITUS ULCER 4 0.0005
706 MOTOR DYSFUNCTION 5 0.0005
707 DRUG INTOLERANCE 47 0.0005
708 HYPERCALCAEMIA 6 0.0005
709 CONSTIPATION 105 0.0005
710 MEMORY IMPAIRMENT 66 0.0005
711 MUSCLE ATROPHY 6 0.0005
712 FEELING JITTERY 9 0.0005
713 OFF LABEL USE 413 0.0005
714 DRUG EXPOSURE DURING PREGNANCY 16 0.0005
715 RESPIRATORY DISORDER 14 0.0005
716 SCAR 8 0.0005
717 SEPSIS 52 0.0005
718 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
719 WOUND 13 0.0005
720 HEPATIC FAILURE 14 0.0005
721 PRURITUS GENERALISED 10 0.0005
722 DIPLOPIA 12 0.0005
723 GENERAL PHYSICAL HEALTH DETERIORATION 53 0.0005
724 BEDRIDDEN 6 0.0005
725 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
726 BLOOD CHOLESTEROL INCREASED 21 0.0005
727 PLEURAL EFFUSION 27 0.0004
728 CHROMATURIA 10 0.0004
729 HEART RATE IRREGULAR 10 0.0004
730 DISEASE RECURRENCE 21 0.0004
731 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
732 PYREXIA 152 0.0004
733 HYPOTHYROIDISM 14 0.0004
734 SYNCOPE 43 0.0004
735 HYPERKALAEMIA 15 0.0004
736 WEIGHT INCREASED 95 0.0004
737 FEELING HOT 26 0.0004
738 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
739 CYTOMEGALOVIRUS INFECTION 7 0.0004
740 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
741 MEDICATION ERROR 23 0.0004
742 VISION BLURRED 56 0.0004
743 INCORRECT DOSE ADMINISTERED 93 0.0004
744 HOSPITALISATION 62 0.0004
745 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
746 AMENORRHOEA 7 0.0004
747 DRUG ERUPTION 7 0.0004
748 HAEMOPTYSIS 11 0.0004
749 ISCHAEMIC STROKE 7 0.0004
750 TINNITUS 18 0.0004
751 EMOTIONAL DISORDER 12 0.0004
752 ALOPECIA 76 0.0004
753 RESTLESS LEGS SYNDROME 7 0.0004
754 NERVOUS SYSTEM DISORDER 12 0.0004
755 SWOLLEN TONGUE 12 0.0004
756 CYANOSIS 6 0.0004
757 PANCREATITIS 20 0.0004
758 LIVER FUNCTION TEST ABNORMAL 11 0.0004
759 VERTIGO 23 0.0004
760 EATING DISORDER 8 0.0004
761 HAIR TEXTURE ABNORMAL 5 0.0004
762 MALIGNANT MELANOMA 5 0.0004
763 DIARRHOEA 240 0.0004
764 DRUG EFFECT DECREASED 20 0.0004
765 GASTRIC ULCER 7 0.0004
766 INFECTION 53 0.0004
767 EYE DISORDER 12 0.0004
768 DRUG INEFFECTIVE 479 0.0004
769 VENTRICULAR TACHYCARDIA 6 0.0004
770 WEIGHT DECREASED 101 0.0004
771 PERICARDITIS 6 0.0004
772 INTESTINAL PERFORATION 4 0.0004
773 CANDIDA INFECTION 6 0.0004
774 CARDIOVASCULAR DISORDER 9 0.0004
775 ANAEMIA 67 0.0004
776 PARALYSIS 5 0.0003
777 ATRIAL FIBRILLATION 34 0.0003
778 BONE MARROW FAILURE 7 0.0003
779 MUSCULOSKELETAL STIFFNESS 30 0.0003
780 ABDOMINAL PAIN 79 0.0003
781 OXYGEN SATURATION DECREASED 19 0.0003
782 DECREASED APPETITE 78 0.0003
783 APHASIA 10 0.0003
784 NAUSEA 262 0.0003
785 BONE DISORDER 6 0.0003
786 PNEUMONIA 106 0.0003
787 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
788 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
789 MYOCARDIAL INFARCTION 56 0.0003
790 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
791 OEDEMA PERIPHERAL 39 0.0003
792 LIVER DISORDER 14 0.0003
793 SLEEP APNOEA SYNDROME 6 0.0003
794 ULCER 5 0.0003
795 MIGRAINE 30 0.0003
796 MOOD SWINGS 10 0.0003
797 ERECTILE DYSFUNCTION 8 0.0003
798 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
799 DRY MOUTH 25 0.0003
800 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
801 ADVERSE EVENT 28 0.0003
802 INFLUENZA LIKE ILLNESS 25 0.0003
803 PRESCRIBED UNDERDOSE 6 0.0003
804 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
805 ILL-DEFINED DISORDER 18 0.0003
806 FEEDING DISORDER 6 0.0003
807 MALAISE 129 0.0003
808 HEART RATE INCREASED 29 0.0003
809 FATIGUE 227 0.0003
810 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
811 INTENTIONAL DRUG MISUSE 6 0.0003
812 CEREBRAL INFARCTION 7 0.0003
813 CONTUSION 27 0.0003
814 THIRST 5 0.0003
815 IMPAIRED QUALITY OF LIFE 4 0.0003
816 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
817 GASTROENTERITIS 4 0.0003
818 DYSURIA 10 0.0003
819 CARDIOMYOPATHY 4 0.0003
820 FALL 90 0.0003
821 HAEMATOMA 7 0.0003
822 EYE SWELLING 10 0.0003
823 HYPERTENSION 56 0.0003
824 FEELING ABNORMAL 63 0.0003
825 FREQUENT BOWEL MOVEMENTS 7 0.0003
826 EJECTION FRACTION DECREASED 4 0.0003
827 BLOOD PRESSURE ABNORMAL 5 0.0003
828 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
829 CARDIAC FAILURE 20 0.0002
830 ASTHMA 28 0.0002
831 DIZZINESS 123 0.0002
832 COLITIS ULCERATIVE 11 0.0002
833 CHOLELITHIASIS 8 0.0002
834 LUNG NEOPLASM MALIGNANT 10 0.0002
835 DRUG DEPENDENCE 39 0.0002
836 TOOTH LOSS 5 0.0002
837 VISUAL ACUITY REDUCED 8 0.0002
838 URINARY TRACT INFECTION 41 0.0002
839 LIP SWELLING 8 0.0002
840 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
841 ANAPHYLACTIC REACTION 13 0.0002
842 CATARACT 14 0.0002
843 THERAPEUTIC RESPONSE DECREASED 14 0.0002
844 ASTHENIA 86 0.0002
845 DEATH 196 0.0002
846 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
847 CARDIAC FAILURE CONGESTIVE 18 0.0002
848 CEREBRAL HAEMORRHAGE 8 0.0002
849 MOBILITY DECREASED 16 0.0002
850 BALANCE DISORDER 19 0.0002
851 PRODUCT AVAILABILITY ISSUE 5 0.0002
852 OSTEOPOROSIS 9 0.0002
853 FLUSHING 22 0.0002
854 BRONCHITIS 16 0.0002
855 BLOOD PRESSURE INCREASED 33 0.0002
856 ROAD TRAFFIC ACCIDENT 9 0.0002
857 HEPATIC CIRRHOSIS 4 0.0002
858 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
859 CHEST PAIN 39 0.0002
860 VISUAL IMPAIRMENT 26 0.0002
861 INCREASED APPETITE 4 0.0002
862 HYPERSOMNIA 6 0.0002
863 PRODUCT USE ISSUE 39 0.0002
864 HERNIA 4 0.0002
865 EAR PAIN 4 0.0002
866 HAEMORRHOIDS 4 0.0002
867 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
868 ACUTE MYOCARDIAL INFARCTION 6 0.0002
869 MUSCULAR WEAKNESS 23 0.0002
870 ABASIA 5 0.0002
871 CYTOKINE RELEASE SYNDROME 4 0.0002
872 EMOTIONAL DISTRESS 24 0.0002
873 STOMATITIS 12 0.0002
874 LYMPHADENOPATHY 7 0.0002
875 NECK PAIN 11 0.0002
876 FEMUR FRACTURE 6 0.0002
877 BONE DENSITY DECREASED 6 0.0002
878 BLOOD GLUCOSE INCREASED 36 0.0002
879 DYSPHONIA 11 0.0002
880 COLITIS 7 0.0002
881 IMPAIRED HEALING 6 0.0002
882 SKIN DISORDER 6 0.0002
883 ABDOMINAL PAIN UPPER 37 0.0002
884 PLASMA CELL MYELOMA 7 0.0002
885 ADVERSE DRUG REACTION 16 0.0002
886 ARTHRITIS 14 0.0002
887 HAEMATURIA 6 0.0002
888 ACCIDENTAL EXPOSURE TO PRODUCT 18 0.0002
889 INFLAMMATION 9 0.0002
890 SKIN DISCOLOURATION 8 0.0002
891 GAIT DISTURBANCE 33 0.0002
892 DYSSTASIA 5 0.0002
893 CHILLS 20 0.0002
894 LABORATORY TEST ABNORMAL 5 0.0002
895 OCULAR HYPERAEMIA 8 0.0002
896 PARAESTHESIA 26 0.0002
897 DRUG EFFECT INCOMPLETE 6 0.0002
898 GYNAECOMASTIA 5 0.0002
899 DYSPNOEA 91 0.0002
900 RASH 69 0.0002
901 ANGIOEDEMA 7 0.0002
902 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
903 ANAPHYLACTIC SHOCK 4 0.0002
904 ABDOMINAL DISTENSION 16 0.0002
905 NEPHROLITHIASIS 7 0.0002
906 RENAL DISORDER 7 0.0002
907 HEPATIC ENZYME INCREASED 10 0.0001
908 RASH ERYTHEMATOUS 7 0.0001
909 HEART RATE DECREASED 5 0.0001
910 INJURY 10 0.0001
911 ANGINA PECTORIS 4 0.0001
912 SWELLING FACE 9 0.0001
913 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
914 MUSCLE SPASMS 25 0.0001
915 CEREBROVASCULAR ACCIDENT 23 0.0001
916 NASOPHARYNGITIS 25 0.0001
917 NEOPLASM MALIGNANT 9 0.0001
918 HYPOAESTHESIA 20 0.0001
919 MUSCULOSKELETAL PAIN 7 0.0001
920 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
921 CORONARY ARTERY DISEASE 4 0.0001
922 HEADACHE 82 0.0001
923 BACK PAIN 30 0.0001
924 CARDIAC DISORDER 12 0.0001
925 PRODUCTIVE COUGH 6 0.0001
926 ABORTION SPONTANEOUS 5 0.0001
927 HIP FRACTURE 4 0.0001
928 HAEMORRHAGE 13 0.0001
929 PAIN 76 0.0001
930 EXTRA DOSE ADMINISTERED 5 0.0001
931 GASTROINTESTINAL DISORDER 11 0.0001
932 LUNG DISORDER 6 0.0001
933 HERPES ZOSTER 7 0.0001
934 COUGH 34 0.0001
935 DYSGEUSIA 9 0.0001
936 DRY EYE 6 0.0001
937 NASAL CONGESTION 7 0.0001
938 SKIN EXFOLIATION 10 0.0001
939 FLUID RETENTION 6 0.0001
940 MYALGIA 20 0.0001
941 THERAPY CESSATION 6 0.0001
942 RECTAL HAEMORRHAGE 5 0.0001
943 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
944 OEDEMA 6 0.0001
945 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
946 ERYTHEMA 22 0.0001
947 EPISTAXIS 8 0.0001
948 UNEVALUABLE EVENT 8 0.0001
949 BLOOD GLUCOSE DECREASED 5 0.0001
950 INTERSTITIAL LUNG DISEASE 5 0.0001
951 BONE PAIN 6 0.0001
952 PRURITUS 38 0.0001
953 INFLUENZA 11 0.0001
954 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
955 THERAPY INTERRUPTED 7 0.0001
956 OROPHARYNGEAL PAIN 9 0.0001
957 HYPERSENSITIVITY 18 0.0001
958 BREAST CANCER 9 0.0001
959 SWELLING 9 0.0001
960 INJECTION SITE SWELLING 7 0.0001
961 DEPENDENCE 5 0.0001
962 HAEMATOCHEZIA 5 0.0001
963 BLISTER 5 0.0001
964 FLATULENCE 5 0.0001
965 PRODUCT SUBSTITUTION ISSUE 5 0.0001
966 PERIPHERAL SWELLING 13 0.0001
967 DISCOMFORT 5 0.0001
968 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
969 ECZEMA 4 0.0001
970 DRY SKIN 10 0.0001
971 ARTHRALGIA 31 0.0001
972 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
973 RHEUMATOID ARTHRITIS 8 0.0001
974 EYE IRRITATION 4 0.0001
975 SINUSITIS 7 0.0001
976 ILLNESS 7 0.0001
977 DRUG DOSE OMISSION 11 0.0001
978 URTICARIA 11 0.0001
979 INJECTION SITE ERYTHEMA 8 0.0001
980 PAIN IN EXTREMITY 18 0.0001
981 BURNING SENSATION 4 0.0001
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
983 PRODUCT DOSE OMISSION ISSUE 16 0.0001
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
985 ABDOMINAL DISCOMFORT 9 0.0001
986 INJECTION SITE PAIN 16 0.0001
987 JOINT SWELLING 6 0.0000
988 PRODUCT QUALITY ISSUE 6 0.0000
989 NO ADVERSE EVENT 7 0.0000
990 PSORIASIS 5 0.0000